insulin glargine   

GtoPdb Ligand ID: 7572

Synonyms: HOE-901 | HOE901 | Lantus®
insulin glargine is an approved drug (FDA and EMA (2000))
Comment: Insulin glargine is a recombinant, modified analogue of human insulin. A fixed-ratio formulation containing insulin glargine and lixisenatide is being assessed in clinical trials for the treatment of type 2 diabetes. Click here to view a list of such trials registered with

Biosimilar drugs: Insulin glargine biosimilar SB9 is in development by Samsung Bioepis
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: glargine

Compound class Peptide or derivative
Approved drug? Yes (FDA and EMA (2000))
International Nonproprietary Names
INN number INN
7548 insulin glargine
HOE-901 | HOE901 | Lantus®
Database Links
CAS Registry No. 160337-95-1
ChEMBL Ligand CHEMBL1201497
DrugBank Ligand DB00047
GtoPdb PubChem SID 223365908
PubChem CID 44146714
Search PubMed clinical trials insulin glargine
Search PubMed titles insulin glargine
Search PubMed titles/abstracts insulin glargine
Wikipedia Insulin glargine